Pepro Tech

This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seet, B. T.
Right arrow Articles by McFadden, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seet, B. T.
Right arrow Articles by McFadden, G.
(Journal of Leukocyte Biology. 2002;72:24-34.)
© 2002 by Society for Leukocyte Biology

Viral chemokine-binding proteins

Bruce T. Seet and Grant McFadden

Department of Microbiology and Immunology, The University of Western Ontario, London, Canada; and Viral Immunology and Pathogenesis Laboratories, The John P. Robarts Research Institute, London, Ontario, Canada

Correspondence: Grant McFadden, The John P. Robarts Research Institute, 1400 Western Road, SDRI Room 133, London, Ontario N6G 2V4 Canada. E-mail: mcfadden{at}rri.on.ca

The chemokines are a large family of small signaling proteins that bind to G-protein-coupled receptors (GPCRs) on target cells and mediate the directional migration of immune cells into sites of infection or inflammation. The large DNA viruses, particularly the poxviruses and herpesviruses, have evolved several mechanisms to corrupt the normal functioning of the chemokine network. Two strategies rely on mimicking chemokines or chemokine receptors. A third strategy involves the production of secreted chemokine-binding proteins (CKBPs) that exhibit no sequence similarity to any known host proteins, yet function to competitively bind and inhibit the interactions of chemokines with cognate receptors. Each strategy has provided unique insights into the elusively complex world of the chemokines. Here, we focus on recent advances made in the understanding of secreted CKBPs encoded by poxviruses and herpesviruses. A better understanding of how viral CKBPs function to manipulate the immune response may provide further clues as to how to develop specific therapeutic agents to abrogate chemokine-mediated disease conditions.

Key Words: poxvirus • herpesvirus • chemokine receptor • viral immune evasion • viral chemokine inhibitor • chemokine antagonist • vCCI • CKBP




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
A. Viejo-Borbolla, A. Munoz, E. Tabares, and A. Alcami
Glycoprotein G from pseudorabies virus binds to chemokines with high affinity and inhibits their function
J. Gen. Virol., January 1, 2010; 91(1): 23 - 31.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
D. Deane, N. Ueda, L. M. Wise, A. R. Wood, A. Percival, C. Jepson, N. F. Inglis, S. B. Fleming, A. A. Mercer, and C. J. McInnes
Conservation and variation of the parapoxvirus GM-CSF-inhibitory factor (GIF) proteins
J. Gen. Virol., April 1, 2009; 90(4): 970 - 977.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Rahbar, T. T. Murooka, and E. N. Fish
Role for CCR5 in Dissemination of Vaccinia Virus In Vivo
J. Virol., March 1, 2009; 83(5): 2226 - 2236.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. R. Van de Walle, B. B. Kaufer, N. Chbab, and N. Osterrieder
Analysis of the Herpesvirus Chemokine-binding Glycoprotein G Residues Essential for Chemokine Binding and Biological Activity
J. Biol. Chem., February 27, 2009; 284(9): 5968 - 5976.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. C. B. Tan, P. S. Goedegebuure, B. A. Belt, B. Flaherty, N. Sankpal, W. E. Gillanders, T. J. Eberlein, C.-S. Hsieh, and D. C. Linehan
Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer
J. Immunol., February 1, 2009; 182(3): 1746 - 1755.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Fodil-Cornu, S.-H. Lee, S. Belanger, A. P. Makrigiannis, C. A. Biron, R. M. Buller, and S. M. Vidal
Ly49h-Deficient C57BL/6 Mice: A New Mouse Cytomegalovirus-Susceptible Model Remains Resistant to Unrelated Pathogens Controlled by the NK Gene Complex
J. Immunol., November 1, 2008; 181(9): 6394 - 6405.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. R. Van de Walle, K. W. Jarosinski, and N. Osterrieder
Alphaherpesviruses and Chemokines: Pas de Deux Not Yet Brought to Perfection
J. Virol., July 1, 2008; 82(13): 6090 - 6097.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Zhang, M. DeRider, M. A. McCornack, S.-c. Jao, N. Isern, T. Ness, R. Moyer, and P. J. LiWang
Solution structure of the complex between poxvirus-encoded CC chemokine inhibitor vCCI and human MIP-1beta
PNAS, September 19, 2006; 103(38): 13985 - 13990.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Rahbar, T. T. Murooka, A. A. Hinek, C. L. Galligan, A. Sassano, C. Yu, K. Srivastava, L. C. Platanias, and E. N. Fish
Vaccinia Virus Activation of CCR5 Invokes Tyrosine Phosphorylation Signaling Events That Support Virus Replication
J. Virol., July 15, 2006; 80(14): 7245 - 7259.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Piqueras, J. Connolly, H. Freitas, A. K. Palucka, and J. Banchereau
Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors
Blood, April 1, 2006; 107(7): 2613 - 2618.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. T. Taylor and W. A. Bresnahan
Human Cytomegalovirus Immediate-Early 2 Protein IE86 Blocks Virus-Induced Chemokine Expression
J. Virol., January 15, 2006; 80(2): 920 - 928.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
P. Smith, R. E. Fallon, N. E. Mangan, C. M. Walsh, M. Saraiva, J. R. Sayers, A. N.J. McKenzie, A. Alcami, and P. G. Fallon
Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity
J. Exp. Med., November 21, 2005; 202(10): 1319 - 1325.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Lucas and G. McFadden
Secreted Immunomodulatory Viral Proteins as Novel Biotherapeutics
J. Immunol., October 15, 2004; 173(8): 4765 - 4774.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. Pyo, K. K. Jensen, M. T. Wiekowski, D. Manfra, A. Alcami, M. B. Taubman, and S. A. Lira
Inhibition of Intimal Hyperplasia in Transgenic Mice Conditionally Expressing the Chemokine-Binding Protein M3
Am. J. Pathol., June 1, 2004; 164(6): 2289 - 2297.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. T. Seet, C. A. McCaughan, T. M. Handel, A. Mercer, C. Brunetti, G. McFadden, and S. B. Fleming
Analysis of an orf virus chemokine-binding protein: Shifting ligand specificities among a family of poxvirus viroceptors
PNAS, December 9, 2003; 100(25): 15137 - 15142.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. L. T. Teoh, P. J. Walasek, and D. H. Evans
Leporipoxvirus Cu,Zn-Superoxide Dismutase (SOD) Homologs Are Catalytically Inert Decoy Proteins That Bind Copper Chaperone for SOD
J. Biol. Chem., August 29, 2003; 278(35): 33175 - 33184.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. B. Johnston and G. McFadden
Poxvirus Immunomodulatory Strategies: Current Perspectives
J. Virol., June 1, 2003; 77(11): 6093 - 6100.
[Full Text] [PDF]